| CLRB Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CLRB market cap history going back to 3/7/2016:
Also see: CLRB Shares Outstanding History and CLRB YTD Return |
CLRB Market Cap History — Cellectar Biosciences Capitalization Over Time
As of 8/11/2026 Cellectar Biosciences has a market cap of 24.95 million. Investors often follow the CLRB market cap history to compare the size of the company over time.
This page shows CLRB market capitalization trends over time, with 46 market cap datapoints presented, dating back to 3/7/2016.
| CLRB Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLRB Historical Market Cap: +20.30% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CLRB Stock Price Chart |
| About Cellectar Biosciences Inc |
| Cellectar Biosciences, Inc. is a late-stage clinical biopharmaceutical company. Co. is focused on the discovery, development and commercialization of drugs for the treatment of cancer. Co., through phospholipid ether drug conjugate (PDC) delivery platform, is focused on developing PDCs that are designed to specifically target cancer cells. Its PDC platform possesses the potential for the discovery and development of cancer-targeting treatments, and it plans to develop PDCs both independently and through research and development collaborations. We show 46 historical shares outstanding datapoints in our CLRB shares outstanding history coverage, used to compute CLRB market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CLRB market cap history over the course of time is important for investors interested in comparing CLRB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CLRB versus a peer is one thing; comparing CLRB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CLRB can fluctuate over the course of history. With this page we aim to empower investors researching CLRB by allowing them to research the CLRB market cap history. |
| CLRB Current Stock Quote |
Quotes delayed 20 minutes  Free CLRB Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CLRB Share Performance |
| Market Cap Peers |
| Cellectar Biosciences (CLRB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CLSD Market Cap History CLSN Market Cap History CLVS Market Cap History CLXT Market Cap History CLYM Market Cap History CMAX Market Cap History CMD Market Cap History CMPI Market Cap History CMPX Market Cap History CMRA Market Cap History More Healthcare companies » |
CLRB Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
